ALBANY, N.Y.--(BUSINESS WIRE)--
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative
medical devices for the minimally-invasive treatment of cancer and
peripheral vascular disease, will present at the 2011 RBC Capital
Markets Healthcare Conference on Wednesday, March 2, 2011, at 2:35 p.m.
ET. Joseph Gersuk, Executive Vice President and Chief Financial Officer
of AngioDynamics, will review the Company's business strategy and recent
corporate developments.
A live webcast of AngioDynamics' presentation may be accessed through
the investor relations section of the Company's Web site at http://investors.angiodynamics.com,
where an archived replay of the presentation also will be available for
30 days after the live presentation.
About AngioDynamics
AngioDynamics, Inc. is a leading provider of innovative medical devices
used by interventional radiologists, surgeons and other physicians for
the minimally-invasive treatment of cancer and peripheral vascular
disease. AngioDynamics' diverse product lines include market-leading
ablation systems, vascular access products, angiographic products and
accessories, dialysis products, angioplasty products, drainage products,
thrombolytic products, embolization products and venous products. More
information is available at www.angiodynamics.com.
AngioDynamics, Inc.
D. Joseph Gersuk, CFO,
800-772-6446 x1608
jgersuk@AngioDynamics.com
or
Investor
Relations Contacts:
EVC Group, Inc.
Doug
Sherk, 415-896-6820
dsherk@evcgroup.com
Gregory
Gin, 415-896-6820
ggin@evcgroup.com
or
Media
Contact:
EVC Group, Inc.
Chris Gale,
646-201-5431
cgale@evcgroup.com
Source: AngioDynamics, Inc.
News Provided by Acquire Media
